We confirmed that all tested HER2+ BC cell lines were ERBB2 gene amplified (ERBB2 gene copy number: > 10) compared to the triple-negative BC cell line MDA-MB-231 that was known to HER2-negative cell line (ERBB2 gene copy number: 1.01) (Fig. S1A). Here, ERBB2 is linked to breast cancer.